Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Nov;74(5):1882–1885. doi: 10.1172/JCI111607

Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients.

S Carrel, F Buchegger, D Heumann, C Girardet, C Barras, G Losa, J P Mach, V von Fliedner
PMCID: PMC425368  PMID: 6334103

Abstract

The common acute lymphoblastic leukemia antigen (CALLA) has been detected in biological fluids using a radioimmunoassay based on the inhibition of binding of 125I-labeled monoclonal anti-CALLA antibody to glutaraldehyde-fixed NALM-1 cells. With this assay, we showed first that CALLA was released in culture fluids from NALM-1 and Daudi cell lines but was absent from culture fluids from CALLA negative cell lines. Then, we found that the sera of 34 out of 42 patients (81%) with untreated common acute lymphoblastic leukemia (c-ALL) contained higher CALLA levels than any of the 42 serum samples from healthy controls. The specificity of these results was further demonstrated by testing in parallel the sera from 48 patients with CALLA negative leukemias, including 26 acute myeloid leukemia (AML), 12 T-cell acute lymphoblastic leukemia (T-ALL), and 10 acute undifferentiated leukemia (AUL). All of these sera gave negative results, except for one patient with AUL, who had a significantly elevated circulating CALLA level, and one patient with AML, who had a borderline CALLA level, 3 SD over the mean of the normal sera. Preliminary results suggest that circulating CALLA is associated with membrane fragments or vesicles, since the total CALLA antigenic activity was recovered in the pellet of the serum samples centrifuged at 100,000 g. In addition, the CALLA-positive pellets contained an enzyme considered as a membrane marker, 5'-nucleotidase. Evaluation of the clinical importance of repeated serum CALLA determinations for the monitoring of c-ALL patients deserves further investigation.

Full text

PDF
1882

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billing R., Clark B., Guidera K., Minowada J. Heteroantiserum against acute lymphocytic leukemia raised to the lymphoblastoid cell line NALM-1. Int J Cancer. 1978 Dec;22(6):694–699. doi: 10.1002/ijc.2910220610. [DOI] [PubMed] [Google Scholar]
  2. Carrel S., De Tribolet N., Gross N. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol. 1982 Apr;12(4):354–357. doi: 10.1002/eji.1830120418. [DOI] [PubMed] [Google Scholar]
  3. Carrel S., Heumann D., Sekaly R. P., Zaech P., Buchegger F., Girardet C. Characterization of a monoclonal antibody (A12) that defines a human acute lymphoblastic leukemia-associated differentiation antigen. Hybridoma. 1983;2(2):149–160. doi: 10.1089/hyb.1983.2.149. [DOI] [PubMed] [Google Scholar]
  4. Carrel S., Schmidt-Kessen A., Mach J. P., Heumann D., Girardet C. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol. 1983 May;130(5):2456–2460. [PubMed] [Google Scholar]
  5. Clavell L. A., Lipton J. M., Bast R. C., Jr, Kudisch M., Pesando J., Scholssman S. F., Ritz J. Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors. Blood. 1981 Aug;58(2):333–336. [PubMed] [Google Scholar]
  6. Greaves M. F., Brown G., Rapson N. T., Lister T. A. Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol. 1975 May;4(1):67–84. doi: 10.1016/0090-1229(75)90041-0. [DOI] [PubMed] [Google Scholar]
  7. Janossy G., Francis G. E., Capellaro D., Goldstone A. H., Greaves M. F. Cell sorter analysis of leukaemia-associated antigens on human myeloid precursors. Nature. 1978 Nov 9;276(5684):176–178. doi: 10.1038/276176a0. [DOI] [PubMed] [Google Scholar]
  8. Kabisch H., Arndt R., Thiele H. G., Winkler K., Landbeck G. Partial molecular characterization of an antigenic structure associated to cells of common acute lymphocytic leukaemia (ALL). Clin Exp Immunol. 1978 Jun;32(3):399–404. [PMC free article] [PubMed] [Google Scholar]
  9. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 1968 Jul;28(7):1300–1310. [PubMed] [Google Scholar]
  10. Koshiba H., Minowada J., Pressman D. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen. J Natl Cancer Inst. 1978 Oct;61(4):987–991. [PubMed] [Google Scholar]
  11. LeBien T. W., Hurwitz R. L., Kersey J. H. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line. J Immunol. 1979 Jan;122(1):82–88. [PubMed] [Google Scholar]
  12. Losa G., Morell A., Barandun S. Correlations between enzymatic and immunologic properties of human peripheral blood mononuclear cells. I. Ectoenzymes of normal and immunodeficient peripheral blood mononuclear cells. Am J Pathol. 1982 May;107(2):191–201. [PMC free article] [PubMed] [Google Scholar]
  13. Metzgar R. S., Borowitz M. J., Jones N. H., Dowell B. L. Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med. 1981 Oct 1;154(4):1249–1254. doi: 10.1084/jem.154.4.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Minowada J., Tsubota T., Greaves M. F., Walters T. R. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J Natl Cancer Inst. 1977 Jul;59(1):83–87. doi: 10.1093/jnci/59.1.83. [DOI] [PubMed] [Google Scholar]
  15. Newman R. A., Sutherland R., Greaves M. F. The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors. J Immunol. 1981 May;126(5):2024–2030. [PubMed] [Google Scholar]
  16. Pesando J. M., Ritz J., Levine H., Terhorst C., Lazarus H., Schlossman S. F. Human leukemia-associated antigen: relation to a family of surface glycoproteins. J Immunol. 1980 Jun;124(6):2794–2799. [PubMed] [Google Scholar]
  17. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  18. Ritz J., Pesando J. M., Notis-McConarty J., Lazarus H., Schlossman S. F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature. 1980 Feb 7;283(5747):583–585. doi: 10.1038/283583a0. [DOI] [PubMed] [Google Scholar]
  19. Sachs D. H., Kiszkiss P., Kim K. J. Release of Ia antigens by a cultured B cell line. J Immunol. 1980 May;124(5):2130–2136. [PubMed] [Google Scholar]
  20. Terres G., Aldo-Benson M., Borel Y. Effect of anti-carrier antibody on carrier-determined tolerance. Eur J Immunol. 1976 Jul;6(7):492–497. doi: 10.1002/eji.1830060709. [DOI] [PubMed] [Google Scholar]
  21. Veit B. C., Melvin S. L., Bowman W. P. Identification of a leukemia-associated antigen of human acute lymphocytic leukemia. J Natl Cancer Inst. 1980 Jun;64(6):1321–1328. doi: 10.1093/jnci/64.6.1321. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES